Editas Medicine Inc (EDIT) earnings · rev $40.5M
These earnings events as JSON? API free 100/dayEditas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
This EDIT earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported EDIT revenue for 2025-12-31 was $40.5M. Net income was -$160.1M. Revenue was up 25.4% from 2024-12-31 to 2025-12-31. EDIT currently screens at market cap $375.2M.
When the next EDIT 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 25.4% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full EDIT research stays on the stock page; the tape stays on the quote page.
EDIT earnings FAQ
What are EDIT's latest revenue and net income?
Latest cached Editas Medicine Inc (EDIT) revenue for Dec 31, 2025 was $40.5M. Net income was -$160.1M. Statements: https://lician.com/financials/edit
What is EDIT's latest diluted EPS?
Latest cached Editas Medicine Inc (EDIT) diluted EPS for Dec 31, 2025 was -$1.80.
What period does the latest EDIT earnings print cover?
The latest cached Editas Medicine Inc (EDIT) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did EDIT revenue change from the prior cached period?
Cached Editas Medicine Inc (EDIT) revenue was up 25.4% from $32.3M (Dec 31, 2024) to $40.5M (Dec 31, 2025). Statements: https://lician.com/financials/edit
Where are EDIT earnings listed?
Cached earnings facts for Editas Medicine Inc (EDIT) are listed at https://lician.com/earnings/edit. Statements: https://lician.com/financials/edit
Not investment advice.